Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget, 6247-6248 [07-577]

Download as PDF 6247 Federal Register / Vol. 72, No. 27 / Friday, February 9, 2007 / Notices There are no costs to the respondents other than their time. The total estimated annualized burden hours are 234. Type of responses or kinds of respondents Number of respondents Number of responses per respondent Average burden per response (in hours) Semi-Annual Report .................................................................................................................... 13 2 9 Dated: February 5, 2007. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–2177 Filed 2–8–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare and Medicaid Services [Document Identifier: CMS–R–262 and CMS–10142] Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget Center for Medicare and Medicaid Services. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare and Medicaid Services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. We are, however, requesting an emergency review of the information collection referenced below. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have submitted to the Office of Management and Budget (OMB) the following requirements for emergency review. We are requesting an emergency review because the collection of this information is needed before the jlentini on PROD1PC65 with NOTICES AGENCY: VerDate Aug<31>2005 21:06 Feb 08, 2007 Jkt 211001 expiration of the normal time limits under OMB’s regulations at 5 CFR Part 1320. This is necessary to ensure compliance with an initiative of the Administration. CMS does not have sufficient time to complete the normal PRA clearance process while making corrections and enhancements to the software and ensuring that organizations have ample time to complete and submit their tools by the statutory deadline in June 2007. The normal PRA clearance process would result in violating this statutory deadline which would prevent Medicare Advantage (MA) and Prescription Drug Plan (PDP) organizations from providing benefits to millions of Medicare beneficiaries. CMS is requesting to continue its use of the Plan Benefit Package software, formulary and Bid Pricing Tool for the collection of benefits, pricing and related information for CY 2008 as part of the annual bidding process. 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Plan Benefit Package (PBP) and Formulary Submission for Medicare Advantage (MA) Plans and Prescription Drug Plans (PDPs); Use: Under the Medicare Modernization Act (MMA), Medicare Advantage (MA) and Prescription Drug Plan (PDP) organizations are required to submit plan benefit packages for all Medicare beneficiaries residing in their service area. CMS requires that MA and PDP organizations submit a completed formulary and PBP as part of the annual bidding process. During this process, organizations prepare their proposed plan benefit packages for the upcoming contract year and submit them to CMS for review and approval. The changes to the PBP include enhancements to the software for describing the out-ofnetwork benefits, Medicare Savings Account (MSA) benefits, Point of Service (POS) benefits, Visitor/Travel benefits, and collecting Medicare Rx information on gap coverage. The changes to the formulary include enhancements to the submission process by developing a drug reference table and by collecting excluded drug indicators, specialty drug indicators, and drug types. The software is more PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 clarifying for the plans to describe its benefits and for the beneficiaries to understand their coverage; Form Number: CMS–R–262 (OMB#: 0938– 0763); Frequency: Yearly; Affected Public: Business or other for-profit and Not-for-profit institutions; Number of Respondents: 450; Total Annual Responses: 4,725; Total Annual Hours: 10,800. 2. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Bid Pricing Tool (BPT) for Medicare Advantage (MA) Plans and Prescription Drug Plans (PDPs); Use: Under the Medicare Prescription Drug, Improvement, and Modernization (MMA), Medicare Advantage organizations (MAO) and Prescription Drug Plans (PDP) are required to submit an actuarial pricing ‘‘bid’’ for each plan offered to Medicare beneficiaries. CMS requires that MAOs and PDPs complete the BPT as part of the annual bidding process. During this process, organizations prepare their proposed actuarial bid pricing for the upcoming contract year and submit them to CMS for review and approval. The purpose of the BPT is to collect the actuarial pricing information for each plan. The BPT calculates the plan’s bid, enrollee premiums, and payment rates. The BPT revisions include structural changes to the MA worksheets and changes to streamline reporting requirements. Form Number: CMS– 10142 (OMB#: 0938–0944); Frequency: Yearly; Affected Public: Business or other for-profit and Not-for-profit institutions; Number of Respondents: 550; Total Annual Responses: 6,050; Total Annual Hours: 42,350. CMS is requesting OMB review and approval of these collections by March 21, 2007, with a 180-day approval period. Written comments and recommendation will be considered from the public if received by the individuals designated below by March 3, 2007. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS’ Web Site address at http://www.cms.hhs.gov/ PaperworkReductionActof1995 or E- E:\FR\FM\09FEN1.SGM 09FEN1 6248 Federal Register / Vol. 72, No. 27 / Friday, February 9, 2007 / Notices mail your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call the Reports Clearance Office on (410) 786– 1326. Interested persons are invited to send comments regarding the burden or any other aspect of these collections of information requirements. However, as noted above, comments on these information collection and recordkeeping requirements must be mailed and/or faxed to the designees referenced below by March 3, 2007: Centers for Medicare and Medicaid Services, Office of Strategic Operations and Regulatory Affairs, Room C4–26–05, 7500 Security Boulevard,Baltimore, MD 21244– 1850, Attn: Bonnie L Harkless; and, OMB Human Resources and Housing Branch, Attention: Carolyn Lovett, New Executive Office Building, Room 10235, Washington, DC 20503. Dated: February 2, 2007. Michelle Shortt, Director, Regulations Development Group, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 07–577 Filed 2–8–07; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings jlentini on PROD1PC65 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Center Review Committee. Date: February 19, 2007. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes Street, Arlington, VA 22202. VerDate Aug<31>2005 21:06 Feb 08, 2007 Jkt 211001 Contact Person: Rita Liu, PhD, Associate Director, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 212, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401, (301) 435–1388, rliu@nida.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, NIDA/ L Conflicts. Date: March 5, 2007. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Metro Center, 775 12th Street NW., Washington, DC 20005. Contact Person: Mark R. Green PhD, Deputy Director, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401, (301) 435–1431, mgreen1@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, NIDA– F Conflicts. Date: March 6, 2007. Time: 2 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Gerald L. McLaughlin, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401, (301) 402–6626, gm145a@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, NIDA– E Conflicts. Date: March 6–7, 2007. Time: 2 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Gerald L. McLaughlin, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd., Bethesda, MD 20892–8401, (301) 402–6626, gm145a@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel NIDA/K Conflicts. Date: March 13, 2007. Time: 5 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel, 8120 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Mark Swieter, PhD, Chief, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6101 Executive Boulevard, Suite 220, Bethesda, MD 20892–7491, (301) 435–1389, ms80x@nih.gov. PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addition Research Programs, National Institutes of Health, HHS) Dated: February 5, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–592 Filed 2–8–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [FEMA–3270–EM] Colorado; Amendment No. 2 to Notice of an Emergency Declaration Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: SUMMARY: This notice amends the notice of an emergency declaration for the State of Colorado (FEMA–3270-EM), dated January 7, 2007, and related determinations. DATES: Effective Date: January 31, 2007. FOR FURTHER INFORMATION CONTACT: Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646–2705. SUPPLEMENTARY INFORMATION: The notice of an emergency declaration for the State of Colorado is hereby amended to include the following area among those areas determined to have been adversely affected by the catastrophe declared an emergency by the President in his declaration of January 7, 2007: Teller County for emergency protective measures (Category B), including snow removal, under the Public Assistance program for any continuous 48-hour period during or proximate to the incident period. (The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund Program; 97.032, Crisis Counseling; 97.033, Disaster Legal Services Program; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance; 97.048, Individuals and Households Housing; 97.049, Individuals and Households Disaster Housing Operations; 97.050 Individuals and Households Program—Other Needs; 97.036, Public Assistance Grants; 97.039, Hazard Mitigation Grant Program.) R. David Paulison, Under Secretary for Federal Emergency Management and Director of FEMA. [FR Doc. E7–2145 Filed 2–8–07; 8:45 am] BILLING CODE 9110–10–P E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 72, Number 27 (Friday, February 9, 2007)]
[Notices]
[Pages 6247-6248]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-577]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare and Medicaid Services

[Document Identifier: CMS-R-262 and CMS-10142]


Emergency Clearance: Public Information Collection Requirements 
Submitted to the Office of Management and Budget

AGENCY: Center for Medicare and Medicaid Services.
    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995, the Centers for Medicare and Medicaid 
Services (CMS), Department of Health and Human Services, is publishing 
the following summary of proposed collections for public comment. 
Interested persons are invited to send comments regarding this burden 
estimate or any other aspect of this collection of information, 
including any of the following subjects: (1) The necessity and utility 
of the proposed information collection for the proper performance of 
the agency's functions; (2) the accuracy of the estimated burden; (3) 
ways to enhance the quality, utility, and clarity of the information to 
be collected; and (4) the use of automated collection techniques or 
other forms of information technology to minimize the information 
collection burden.
    We are, however, requesting an emergency review of the information 
collection referenced below. In compliance with the requirement of 
section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have 
submitted to the Office of Management and Budget (OMB) the following 
requirements for emergency review. We are requesting an emergency 
review because the collection of this information is needed before the 
expiration of the normal time limits under OMB's regulations at 5 CFR 
Part 1320. This is necessary to ensure compliance with an initiative of 
the Administration. CMS does not have sufficient time to complete the 
normal PRA clearance process while making corrections and enhancements 
to the software and ensuring that organizations have ample time to 
complete and submit their tools by the statutory deadline in June 2007. 
The normal PRA clearance process would result in violating this 
statutory deadline which would prevent Medicare Advantage (MA) and 
Prescription Drug Plan (PDP) organizations from providing benefits to 
millions of Medicare beneficiaries.
    CMS is requesting to continue its use of the Plan Benefit Package 
software, formulary and Bid Pricing Tool for the collection of 
benefits, pricing and related information for CY 2008 as part of the 
annual bidding process.
    1. Type of Information Collection Request: Revision of a currently 
approved collection; Title of Information Collection: Plan Benefit 
Package (PBP) and Formulary Submission for Medicare Advantage (MA) 
Plans and Prescription Drug Plans (PDPs); Use: Under the Medicare 
Modernization Act (MMA), Medicare Advantage (MA) and Prescription Drug 
Plan (PDP) organizations are required to submit plan benefit packages 
for all Medicare beneficiaries residing in their service area. CMS 
requires that MA and PDP organizations submit a completed formulary and 
PBP as part of the annual bidding process. During this process, 
organizations prepare their proposed plan benefit packages for the 
upcoming contract year and submit them to CMS for review and approval. 
The changes to the PBP include enhancements to the software for 
describing the out-of-network benefits, Medicare Savings Account (MSA) 
benefits, Point of Service (POS) benefits, Visitor/Travel benefits, and 
collecting Medicare Rx information on gap coverage. The changes to the 
formulary include enhancements to the submission process by developing 
a drug reference table and by collecting excluded drug indicators, 
specialty drug indicators, and drug types. The software is more 
clarifying for the plans to describe its benefits and for the 
beneficiaries to understand their coverage; Form Number: CMS-R-262 
(OMB: 0938-0763); Frequency: Yearly; Affected Public: Business 
or other for-profit and Not-for-profit institutions; Number of 
Respondents: 450; Total Annual Responses: 4,725; Total Annual Hours: 
10,800.
    2. Type of Information Collection Request: Revision of a currently 
approved collection; Title of Information Collection: Bid Pricing Tool 
(BPT) for Medicare Advantage (MA) Plans and Prescription Drug Plans 
(PDPs); Use: Under the Medicare Prescription Drug, Improvement, and 
Modernization (MMA), Medicare Advantage organizations (MAO) and 
Prescription Drug Plans (PDP) are required to submit an actuarial 
pricing ``bid'' for each plan offered to Medicare beneficiaries. CMS 
requires that MAOs and PDPs complete the BPT as part of the annual 
bidding process. During this process, organizations prepare their 
proposed actuarial bid pricing for the upcoming contract year and 
submit them to CMS for review and approval. The purpose of the BPT is 
to collect the actuarial pricing information for each plan. The BPT 
calculates the plan's bid, enrollee premiums, and payment rates. The 
BPT revisions include structural changes to the MA worksheets and 
changes to streamline reporting requirements. Form Number: CMS-10142 
(OMB: 0938-0944); Frequency: Yearly; Affected Public: Business 
or other for-profit and Not-for-profit institutions; Number of 
Respondents: 550; Total Annual Responses: 6,050; Total Annual Hours: 
42,350.
    CMS is requesting OMB review and approval of these collections by 
March 21, 2007, with a 180-day approval period. Written comments and 
recommendation will be considered from the public if received by the 
individuals designated below by March 3, 2007.
    To obtain copies of the supporting statement and any related forms 
for the proposed paperwork collections referenced above, access CMS' 
Web Site address at http://www.cms.hhs.gov/PaperworkReductionActof1995 
or E-

[[Page 6248]]

mail your request, including your address, phone number, OMB number, 
and CMS document identifier, to Paperwork@cms.hhs.gov, or call the 
Reports Clearance Office on (410) 786-1326.
    Interested persons are invited to send comments regarding the 
burden or any other aspect of these collections of information 
requirements. However, as noted above, comments on these information 
collection and recordkeeping requirements must be mailed and/or faxed 
to the designees referenced below by March 3, 2007:

Centers for Medicare and Medicaid Services, Office of Strategic 
Operations and Regulatory Affairs, Room C4-26-05, 7500 Security 
Boulevard,Baltimore, MD 21244-1850, Attn: Bonnie L Harkless; and,
OMB Human Resources and Housing Branch, Attention: Carolyn Lovett, New 
Executive Office Building, Room 10235, Washington, DC 20503.

    Dated: February 2, 2007.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations 
and Regulatory Affairs.
[FR Doc. 07-577 Filed 2-8-07; 8:45 am]
BILLING CODE 4120-01-P